Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-067036
Filing Date
2014-11-06
Accepted
2014-11-06 16:47:00
Documents
1
Period of Report
2014-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4144
  Complete submission text file 0001209191-14-067036.txt   5503
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
STEIN EVAN A. (Reporting) CIK: 0001620461 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 141201439